SCHEMBL21383553

SCHEMBL21383553

CCN(C)C(=N)c1cc(C)c(Sc2cccc(OC(F)(F)C(F)F)c2)cc1C

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 17/20 0.36
▸ SCN9A Q15858 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30166535 0.89 ACHE (0.34) ALDH1A1
SCHEMBL20920141 0.89 ACHE (0.34) ALDH1A1
SCHEMBL29624511 0.87 CFTR (0.31) —
SCHEMBL19973881 0.86 SLC6A2 (0.33) ALDH1A1
SCHEMBL30028163 0.77 — —
SCHEMBL15023446 0.76 CETP (0.32) CETP
SCHEMBL29367765 0.76 CETP (0.32) CETP
SCHEMBL15023447 0.76 CETP (0.32) CETP
SCHEMBL17698488 0.76 CETP (0.32) CETP
SCHEMBL18703868 0.74 MAPT (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651716-A1 SOPHOROLIPIDS AND SOPHOROLIPID DERIVATIVES AS TANK MIX ADDITIVES AND ADJUVANTS IN CROP PROTECTION FORMULATIONS Locus Solutions IPCO, LLC (US) 2025-11-26 — — EP disclosed
WO-2024137625-A1 SOPHOROLIPIDS AND SOPHOROLIPID DERIVATIVES AS TANK MIX ADDITIVES AND ADJUVANTS IN CROP PROTECTION FORMULATIONS LOCUS SOLUTIONS IPCO, LLC (US) 2024-06-27 — — WO disclosed
US-20230026494-A1 SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIALS AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 — — US disclosed
WO-2019183454-A1 AQUEOUS NEMATICIDAL COMPOSITIONS CONTAINING DISPERSANTS TO INHIBIT CRYSTAL GROWTH MONSANTO TECHNOLOGY LLC (US) 2019-09-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026494-A1 SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIALS AGENTS FDPS, PGLS, GMDS CETP 1474/4885SCN9A 3875/4885ALDH1A1 4510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback